Drug intelligence / Profile preview

calcipotriol + halometasone

Development stage
Preclinical
Lead developer
LEO Pharma
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Calcipotriol + halometasone is a fixed-dose topical combination of two active ingredients used primarily in the treatment of plaque psoriasis and other inflammatory skin conditions. Calcipotriol is a synthetic vitamin D3 analog that modulates keratinocyte proliferation and differentiation by binding to the vitamin D receptor, thereby reducing excessive skin cell growth characteristic of psoriasis. Halometasone is a potent synthetic corticosteroid that acts as an anti-inflammatory, immunosuppressive, and antipruritic agent by binding to the glucocorticoid receptor, inhibiting pro-inflammatory cytokine production and suppressing immune responses in the skin. The combination leverages both agents' mechanisms for improved efficacy over monotherapy with either component alone.

Brand names
None known (no widely recognized brand name for this specific combination; see comments)
02

Targets

VDR (Vitamin D receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on calcipotriol + halometasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcipotriol + halometasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call